rubiadin has been researched along with Alloxan Diabetes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahad, A; Akhtar, M; Aqil, M; Moolakkadath, T; Mujeeb, M; Najmi, AK; Qadir, A; Shrivastava, A; Siddiqui, WA | 1 |
1 other study(ies) available for rubiadin and Alloxan Diabetes
| Article | Year |
|---|---|
Ameliorative effect of rubiadin-loaded nanocarriers in STZ-NA-induced diabetic nephropathy in rats: formulation optimization, molecular docking, and in vivo biological evaluation.
Topics: Animals; Anthraquinones; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Liposomes; Molecular Docking Simulation; Niacinamide; Rats; Rats, Wistar; Streptozocin | 2022 |